Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/02/24 08:05:00 on US and Canada Markets.
MELBOURNE, Australia, April 02, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to report the company’s new digital stra...
Trend Micro Zero Day Initiative™ Sheds Light on Software Vulnerabilities: Customers Protected up to 70 Days Before Patches PR Newswire ZDI pays over $1 million to researchers in hacking contest targeting web browsers, enterprise software and more DALLAS ...
Event to Offer Interactive Booth Experiences Featuring Leading Dental Technology, Educational Courses, and Networking Opportunities Henry Schein, Inc. (Nasdaq: HSIC) announced today that it will host THRIVELIVE™ 2024, the Company’s annual dental event that celebrates innov...
Received alignment with FDA for broad retinitis pigmentosa (RP) indication in Phase 3 clinical trial of OCU400—first gene therapy program to receive a broad indication for RP. OCU400 Phase 3 clinical trial expected to commence in April 2024. Regenerative Medicine Advanced Therapy (...
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today it will issue its financial results for the three months ended March 31, 2024 after markets close on: Wednesday, May 8, 2024 ...
BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024...
2024-04-02 08:00:09 ET Scot Ciccarelli from Truist Financial issued a price target of $167.00 for GPC on 2024-04-02 07:17:00. The adjusted price target was set to $167.00. At the time of the announcement, GPC was trading at $154.28. The overall price target consensus is ...
2024-04-02 08:00:09 ET Scot Ciccarelli from Truist Financial issued a price target of $277.00 for TSCO on 2024-04-02 07:18:00. The adjusted price target was set to $277.00. At the time of the announcement, TSCO was trading at $258.24. The overall price target consensus i...
2024-04-02 08:00:08 ET John Staszak from Argus Research issued a price target of $88.00 for MKC on 2024-04-02 07:14:00. The adjusted price target was set to $88.00. At the time of the announcement, MKC was trading at $76.62. The overall price target consensus is at $80.8...
2024-04-02 08:00:08 ET Michael Eisen from RBC Capital issued a price target of $325.00 for GD on 2024-04-02 07:16:00. The adjusted price target was set to $325.00. At the time of the announcement, GD was trading at $291.55. The overall price target consensus is at $252.0...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
16.4%Change Percent:
MEI Pharma Inc. Company Name:
MEIP Stock Symbol:
NASDAQ Market:
meipharma.com Website: